205 related articles for article (PubMed ID: 38377037)
1. Logic "AND Gate Circuit"-Based Gasdermin Protein Expressing Nanoplatform Induces Tumor-Specific Pyroptosis to Enhance Cancer Immunotherapy.
Wang X; Zhang W; Wang Y; Zhu X; Liu Z; Liu M; Wu Z; Li B; Liu S; Liao S; Zhu P; Liu B; Li C; Wang Y; Chen Z
ACS Nano; 2024 Mar; 18(9):6946-6962. PubMed ID: 38377037
[TBL] [Abstract][Full Text] [Related]
2. Biomimetic-gasdermin-protein-expressing nanoplatform mediates tumor-specific pyroptosis for cancer immunotherapy.
Wang X; Wang Y; Zhang W; Zhu X; Liu Z; Liu M; Liu S; Li B; Chen Y; Wang Z; Zhu P; Zhao W; Wang Y; Chen Z
J Control Release; 2024 Mar; 367():61-75. PubMed ID: 38242210
[TBL] [Abstract][Full Text] [Related]
3. Circulating immunotherapy strategy based on pyroptosis and STING pathway: Mn-loaded paclitaxel prodrug nanoplatform against tumor progression and metastasis.
Wang B; Wang T; Jiang T; Li S; Zhang L; Zhao X; Yang X; Wang X
Biomaterials; 2024 Apr; 306():122472. PubMed ID: 38280315
[TBL] [Abstract][Full Text] [Related]
4. Pyroptosis, inflammasome, and gasdermins in tumor immunity.
Ouyang X; Zhou J; Lin L; Zhang Z; Luo S; Hu D
Innate Immun; 2023 Jan; 29(1-2):3-13. PubMed ID: 36632024
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous Activation of Pyroptosis and cGAS-STING Pathway with Epigenetic/ Photodynamic Nanotheranostic for Enhanced Tumor Photoimmunotherapy.
Ding F; Liu J; Ai K; Xu C; Mao X; Liu Z; Xiao H
Adv Mater; 2024 Feb; 36(7):e2306419. PubMed ID: 37796042
[TBL] [Abstract][Full Text] [Related]
6. Pyroptosis: A road to next-generation cancer immunotherapy.
Fang Y; Tang Y; Huang B
Semin Immunol; 2023 Jul; 68():101782. PubMed ID: 37302166
[TBL] [Abstract][Full Text] [Related]
7. Sodium Citrate Nanoparticles Induce Dual-Path Pyroptosis for Enhanced Antitumor Immunotherapy through Synergistic Ion Overload and Metabolic Disturbance.
Li J; Ding B; Tan J; Chen H; Meng Q; Li X; Zheng P; Ma P; Lin J
Nano Lett; 2023 Nov; 23(21):10034-10043. PubMed ID: 37903236
[TBL] [Abstract][Full Text] [Related]
8. mRNA lipid nanoparticle-mediated pyroptosis sensitizes immunologically cold tumors to checkpoint immunotherapy.
Li F; Zhang XQ; Ho W; Tang M; Li Z; Bu L; Xu X
Nat Commun; 2023 Jul; 14(1):4223. PubMed ID: 37454146
[TBL] [Abstract][Full Text] [Related]
9. Pyroptosis and the cellular consequences of gasdermin pores.
Huston HC; Anderson MJ; Fink SL
Semin Immunol; 2023 Sep; 69():101803. PubMed ID: 37437353
[TBL] [Abstract][Full Text] [Related]
10. Lighting a Fire: Can We Harness Pyroptosis to Ignite Antitumor Immunity?
Zhang Z; Zhang Y; Lieberman J
Cancer Immunol Res; 2021 Jan; 9(1):2-7. PubMed ID: 33397791
[TBL] [Abstract][Full Text] [Related]
11. The Role of Gasdermin-D-Mediated Pyroptosis in Organ Injury and Its Therapeutic Implications.
Mulla J; Katti R; Scott MJ
Organogenesis; 2023 Dec; 19(1):2177484. PubMed ID: 36967609
[TBL] [Abstract][Full Text] [Related]
12. Posttranslational and Therapeutic Control of Gasdermin-Mediated Pyroptosis and Inflammation.
Fischer FA; Chen KW; Bezbradica JS
Front Immunol; 2021; 12():661162. PubMed ID: 33868312
[TBL] [Abstract][Full Text] [Related]
13. Gasdermins and cancers.
Hou J; Li T; Hsu JM; Zhang X; Hung MC
Semin Immunol; 2023 Nov; 70():101833. PubMed ID: 37647772
[TBL] [Abstract][Full Text] [Related]
14. Biochemical Methods for Assessing Gasdermin D Inactivation in Macrophages.
Humphries F
Methods Mol Biol; 2023; 2641():125-133. PubMed ID: 37074646
[TBL] [Abstract][Full Text] [Related]
15. Virus-Like Particle-Induced cGAS-STING Activation and AIM2 Inflammasome-Mediated Pyroptosis for Robust Cancer Immunotherapy.
Xu X; Fan H; Yang Y; Yao S; Yu W; Guo Z; Tan W
Angew Chem Int Ed Engl; 2023 Jun; 62(24):e202303010. PubMed ID: 37040149
[TBL] [Abstract][Full Text] [Related]
16. Gasdermin D: A Potential New Auxiliary Pan-Biomarker for the Detection and Diagnosis of Diseases.
Wan N; Shi J; Xu J; Huang J; Gan D; Tang M; Li X; Huang Y; Li P
Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002346
[TBL] [Abstract][Full Text] [Related]
17. Gasdermins: a dual role in pyroptosis and tumor immunity.
Yang J; Jiang J
Front Immunol; 2024; 15():1322468. PubMed ID: 38304430
[TBL] [Abstract][Full Text] [Related]
18. Gas-Amplified Metalloimmunotherapy with Dual Activation of Pyroptosis and the STING Pathway for Remodeling the Immunosuppressive Cervical Cancer Microenvironment.
Liu L; Lei H; Hou G; Zhang L; Chen Y; Lu Y; Pei Z; Ge J; Wu J; Zhou J; Cheng L
ACS Nano; 2024 May; 18(20):12830-12844. PubMed ID: 38709246
[TBL] [Abstract][Full Text] [Related]
19. A self-assembling CXCR4-targeted pyroptosis nanotoxin for melanoma therapy.
Zhao Z; Huang Y; Wang J; Lin H; Cao F; Li S; Li Y; Li Z; Liu X
Biomater Sci; 2023 Mar; 11(6):2200-2210. PubMed ID: 36745434
[TBL] [Abstract][Full Text] [Related]
20. Protein engineering reveals that gasdermin A preferentially targets mitochondrial membranes over the plasma membrane during pyroptosis.
Kondolf HC; D'Orlando DA; Dubyak GR; Abbott DW
J Biol Chem; 2023 Feb; 299(2):102908. PubMed ID: 36642180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
